| 发明名称 |
TRICYCLIC LACTONES FOR TREATMENT OF CANCER |
| 摘要 |
The present invention discloses novel compounds useful for the inhibition of IL-6/STAT signaling and/or PI3K/NF-kappaB signaling in the treatment of associated diseases or conditions, e.g. cancer. A pharmaceutical composition comprising such novel compounds, its use and a method thereof, is also disclosed.
|
| 申请公布号 |
US2013310451(A1) |
申请公布日期 |
2013.11.21 |
| 申请号 |
US201113811015 |
申请日期 |
2011.07.18 |
| 申请人 |
GIDLOEF RITHA;JOHANSSON MARTIN;STERNER OLOV;MUNOZ EDUARDO;GLACTONE PHARMA DEVELOPMENT AB |
发明人 |
GIDLOEF RITHA;JOHANSSON MARTIN;STERNER OLOV;MUNOZ EDUARDO |
| 分类号 |
C07D307/93;A61K31/336;A61K31/365;A61K45/06;C07D303/40 |
主分类号 |
C07D307/93 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
